Confirmed: Vegas Shooting Suspect Prescribed Dangerous Drugs – Just Like Many Previous Mass Shooters

This is the second instance in which The Duran has accurately predicted a reality of the Vegas suspect’s profile.

The Las Vegas Review-Journal has obtained information that Stephen Paddock, the suspect in the largest mass shooting in modern US history was prescribed a powerful psychotropic drug called diazepam in June of this year, just under four months prior to the shooting.

This fits a decades-long trend among mass shooters and others who engage in cruel and unusual criminal acts being on powerful, yet legal psychotropic drugs.

According to reports from Las Vegas journalists,

“Records from the Nevada Prescription Monitoring Program obtained Tuesday show Paddock was prescribed 50 10-milligram diazepam tablets by Henderson physician Dr. Steven Winkler on June 21. A woman who answered the phone at Winkler’s office would not make him available to answer questions and would neither confirm nor deny that Paddock was ever a patient.

Paddock purchased the drug — its brand name is Valium — without insurance at a Walgreens store in Reno on the same day it was prescribed. He was supposed to take one pill a day.

Diazepam is a sedative-hypnotic drug in the class of drugs known as benzodizepines, which studies have shown can trigger aggressive behaviour. Chronic use or abuse of sedatives such as diazepam can also trigger psychotic experiences, according to drugabuse.com”.

According to the Nevada state monitoring report, the suspect Stephen Paddock was first prescribed the drugs in 2016.

This validates an earlier report in The Duran which questioned whether the suspect in the Las Vegas mass shooting was taking powerful psychotropic drugs as were most previous mass shooters.

 


Articles by: Adam Garrie

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]